Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Transcriptional Repressor
100%
Methotrexate
100%
Apoptosis Induction
100%
Anaplastic Large Cell Lymphoma
100%
Signal Transducer
100%
Lymphoma Cells
100%
Nucleophosmin 1 (NPM1)
100%
Anaplastic Lymphoma Kinase-positive
100%
Transcription Factor E3 (TFE3)
100%
Anaplastic Lymphoma Kinase
66%
Phosphorylation
11%
DNA Damage
11%
Apoptosis
11%
Anti-apoptotic Proteins
11%
Methylenetetrahydrofolate Reductase (MTHFR)
11%
Co-treatment
11%
Point mutation
11%
Potential Therapeutics
11%
Cytotoxic Effect
11%
Transformed Cells
11%
Resistant Cells
11%
Tumor Protein p53 (TP53)
11%
Downstream Molecules
11%
Myeloid Cell leukemia-1 (Mcl-1)
11%
Chromosomal Translocation
11%
Lymphoma Patients
11%
Inhibitor Resistant
11%
Low-dose Methotrexate
11%
Multiple Cancers
11%
Folinic Acid
11%
ALK Inhibitor
11%
Oncogenic Fusion Protein
11%
Tetrahydrofolate
11%
Therapeutic Applications
11%
Patient-derived
11%
Pharmacology, Toxicology and Pharmaceutical Science
Transcription Factor 3
100%
Methotrexate
100%
Nucleophosmin
100%
STAT Protein
100%
Anaplastic Lymphoma Kinase
100%
Anaplastic Large Cell Lymphoma
100%
Antiinfective Agent
11%
Carcinogenesis
11%
Antiapoptotic
11%
Protein P53
11%
Chimeric Protein
11%
Folinic Acid
11%
Multiple Cancer
11%
Chromosome Translocation
11%
Tumor Suppressor Protein
11%
Anaplastic Lymphoma Kinase Inhibitor
11%
Dihydrofolate Reductase
11%
Tetrahydrofolic Acid
11%
Cytotoxicity
11%
Immunology and Microbiology
Transcription Factor 3
100%
Methotrexate
100%
STAT Protein
100%
Lymphoma Cell
100%
Anaplastic Lymphoma Kinase
100%
Programmed Cell Death
100%
Downregulation
11%
Cytotoxicity
11%
DNA Damage
11%
Low Drug Dose
11%
Point Mutation
11%
P53
11%
Transformed Cell
11%
Chromosome Translocation
11%
phosphorylation
11%